These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17673689)

  • 1. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.
    Shintani Y; Maeda M; Chaika N; Johnson KR; Wheelock MJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):95-104. PubMed ID: 17673689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
    Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
    Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells.
    Petrella BL; Armstrong DA; Vincenti MP
    Cancer Lett; 2012 Dec; 325(2):220-6. PubMed ID: 22796605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
    Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
    Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.
    Beck TN; Korobeynikov VA; Kudinov AE; Georgopoulos R; Solanki NR; Andrews-Hoke M; Kistner TM; Pépin D; Donahoe PK; Nicolas E; Einarson MB; Zhou Y; Boumber Y; Proia DA; Serebriiskii IG; Golemis EA
    Cell Rep; 2016 Jul; 16(3):657-71. PubMed ID: 27396341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells.
    Joannes A; Grelet S; Duca L; Gilles C; Kileztky C; Dalstein V; Birembaut P; Polette M; Nawrocki-Raby B
    Mol Cancer Res; 2014 May; 12(5):775-83. PubMed ID: 24464917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine PDGFR signaling promotes mammary cancer metastasis.
    Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
    J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells.
    Feng H; Liu Q; Zhang N; Zheng L; Sang M; Feng J; Zhang J; Wu X; Shan B
    Oncol Res; 2013; 21(3):165-71. PubMed ID: 24512731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAL-1/4.1B contributes to epithelial-mesenchymal transition via regulation of transforming growth factor-β in lung cancer cell lines.
    Yu F; Yang H; Zhang Z; Wang Z; Xiong J
    Mol Med Rep; 2015 Oct; 12(4):6072-8. PubMed ID: 26300315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.